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Summary
Calorie restriction (CR) remains the most robust intervention to
extend lifespan and improve health span. Using a global mass
spectrometry-based metabolomic approach, we identified 193
metabolites that were significantly differentially expressed (SDE)
in the livers of C57BL/6 mice, fed graded levels of CR (10, 20, 30
and 40% CR) compared to mice fed ad libitum for 12 h a day. The
differential expression of metabolites also varied with the
different feeding groups. Pathway analysis revealed that graded
CR had an impact on carnitine synthesis and the carnitine shuttle
pathway, sphingosine-1-phosphate (S1P) signalling and methion-
ine metabolism. S1P, sphingomyelin and L-carnitine were nega-
tively correlated with body mass, leptin, insulin-like growth
factor- 1 (IGF-1) and major urinary proteins (MUPs). In addition,
metabolites which showed a graded effect, such as ceramide,
S1P, taurocholic acid and L-carnitine, responded in the opposite
direction to previously observed age-related changes. We sug-
gest that the modulation of this set of metabolites may improve
liver processes involved in energy release from fatty acids. S1P
also negatively correlated with catalase activity and body tem-
perature, and positively correlated with food anticipatory activ-
ity. Injecting mice with S1P or an S1P receptor 1 agonist did not
precipitate changes in body temperature, physical activity or food
intake suggesting that these correlations were not causal
relationships.
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Introduction
Human lifespan continues to increase at, on average, two years per
decade (Kirkwood, 2008). This increase in lifespan has persisted over the
last two centuries and has resulted in age becoming a major risk factor in
the most prevalent clinical conditions, which include cancer, cardiovas-
cular disease and dementia. To attenuate these age-associated clinical
conditions, many approaches, in a variety of model organisms, have
been investigated (reviewed in Fontana et al., 2010). Although the
effects of aging have been partially reversed though genetic mutations,
drugs and environmental changes, calorie restriction (CR) is the only
nongenetic technique that consistently increases lifespan (Tosato et al.,
2007; Speakman & Mitchell, 2011). The impacts of CR have been well
documented in rodents, where it improves health span and increases
lifespan (Richard Weindruch, 1988; Speakman et al., 2016). The
beneficial effects of CR are observed in many other species, ranging
from nematode worms to nonhuman primates (Speakman & Mitchell,
2011; Colman et al., 2014).
The mechanisms that result in CR induced increases in lifespan and
decreases in age-associated diseases have yet to be fully explained. This
is in part due to complexity of the aging process and the shift from
healthy aging to pathological disease-associated aging. In rodents, an
increase in CR causes a corresponding increase in lifespan, a relationship
which suggests a close link between aging and nutrient metabolism
(Speakman et al., 2016).
The liver is a key organ in the regulation of lipid and glucose
homeostasis. Relative to other organs, the liver does not display
marked changes with age; however, it is associated with a loss of
hepatic volume and hepatic perfusion (Schmucker & Sanchez, 2011).
Liver cellular structure shows age-associated increases in cell size and a
decrease in the number of mitochondria, in both rodents (Herbener,
1976) and humans (de la Cruz et al., 1990). The destabilization of
mitochondrial processes is thought to be an early marker, or possibly a
cause, of aging and age-related disorders (Rector et al., 2010). These
age-associated deteriorations have a part to play in the marked
increase in mortality from liver disease in the elderly (Regev & Schiff,
2001).
Several important functions in the liver are regulated by insulin,
including protein and lipid synthesis, lipid storage, glycolysis, glucose
storage, gluconeogenesis and the inhibition of ketogenesis (Shaham
et al., 2008). With age, insulin resistance and visceral adiposity increase,
this can cause an increase in inflammation and interfere with systemic
glucose and lipid metabolism (Shoelson et al., 2006; Sepe et al., 2011).
The increase and redistribution of adipose tissue increase leptin and
insulin resistance, which effects the regulation of energy balance
(Friedman, 2011). This increase in adiposity is in part thought to be
due to a shift towards lipogenesis. CR has been suggested to ameliorate
age-associated changes in the liver by decreasing lipogenesis, leptin and
free fatty acids (Kuhla et al., 2014).
We would expect an increase in the level of CR to have an
incremental effect on liver metabolism, as many liver processes are
regulated through nutritional signals such as carbohydrate and amino
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acid levels (Meijer, 2003; Wei et al., 2007). We performed an untargeted
metabolomic analysis on the livers of calorie restricted and control mice
using liquid chromatography–mass spectrometry (LC-MS). Using restric-
tion levels of 10–40% allowed us to identify metabolites which show a
graded response to the intensity of CR, as we expected these
metabolites to be most significantly related to lifespan-associated
changes, due to the linear effect of the level of restriction on longevity
(Speakman et al., 2016).
Results
CR induced changes in the liver metabolome
Male mice were aged 20 weeks when they began CR for 12 weeks. Two
control groups, 12- and 24-h ad libitum access to food (12AL and 24AL,
respectively) were used, plus four levels of CR; 10, 20, 30 and 40%
restriction from baseline food intake. 12AL was used as the control
group for all comparisons, food was given at 1830 h (as with the CR
mice) and removed 12 h later to alleviate the ‘time since last meal’
effect, as all mice had been food deprived for at least 7.5 h before
culling. We found 886 unique metabolites, of which 193 were
significantly differentially expressed (SDE) between the four CR levels
relative to 12AL (adjusted P-value ≤0.05). As the level of restriction
increased, the number of SDE metabolites also rose (Table 1). Of the 193
metabolites, 88 were unique to 40CR, 23 were unique to 30CR, and
three were unique to 20CR (Fig. 1A). Of the SDE 20CR metabolites,
92% overlapped with 30 and 40CR, and 73% of the SDE 30CR
metabolites were also found in 40CR (All SDE metabolites are detailed in
Table S1). We found one metabolite that was SDE by all levels of CR,
putatively identified as D-ribonate, a by-product of glycogen breakdown.
We performed an orthogonal signal correction partial least-squares
discriminant analysis (O-PLS-DA) on metabolites that were SDE between
12AL and at least one CR group using Fisher’s exact test (Fig. 1B,
adjusted P-value ≤0.05). The model indicated that around 60% of the
variance in the metabolites could be explained by the dietary treatment
group (single-sample t-test between model parameters and permuted
parameters, P-value <0.001).
Metabolic pathway changes in response to CR
We identified metabolic pathways using ingenuity pathway analysis (IPA)
andmummichog. We inputted identified SDE metabolites into IPA which
gave us significantly altered metabolic pathways (Table 2) and metabo-
lites (Table S2), relative to 12AL. Ceramide and sphingosine-1-phosphate
(S1P) signalling featured in the top three pathways for all four levels of
CR (Fig. 2, P < 0.001 for all treatment levels). In 20, 30 and 40CR, the
methionine salvage II pathway was in the top three pathways (P < 0.001
for all groups). At 30 and 40CR, L-carnitine biosynthesis (Fig. 3) was
significantly altered (P = 0.001 and P = 0.003, respectively) and all the
identified metabolites (n = 3) were upregulated. In the top ten increased
metabolites for 40CR relative to 12AL, three metabolites were involved
in carnitine metabolism/signalling; L-palmitoylcarnitine (P ≤ 0.001),
acetyl-L-carnitine (P = 0.003) and propionylcarnitine (P < 0.001). At
40CR, sphingomyelin metabolism was significantly altered relative to
12AL (P < 0.001), with 50% of metabolites upregulated and 17%
downregulated.
We used metabolite set enrichment to obtain putative metabolite
identifications and significantly changed pathways based on mass–
charge (m/z) ratios using mummichog (Table 3). Metabolites for each
comparison (CR relative to 12AL) were considered significant if P ≤ 0.05
and were evaluated alongside a reference list of all metabolites found in
the sample. In 40CR, the carnitine shuttle pathway, several amino acid
pathways, vitamin B3 metabolism and fatty acid b-oxidation were the
most significantly altered pathways relative to 12AL. For 30CR, the
carnitine shuttle pathway was also significant relative to 12AL, in
addition to pyrimidine, amino acid and butanoate metabolism. Carnitine
shuttling was the most significantly altered pathway at 20CR, which also
included fatty acid b-oxidation. Saturated fatty acid b-oxidation was
significant for both 20 and 40CR (P = 0.047 and P = 0.014 respectively)
which is also linked to the shuttle of long-chain fatty acids across the
mitochondrial membranes by carnitines. The pathways significant for
10CR included amino acid and glycerophospholipid metabolism
(P = 0.02).
Twelve-hour ad libitum vs. 24-h ad libitum
No metabolites were SDE between 24AL and 12AL (adjusted P ≤ 0.05).
When we relaxed the significance criteria and used the unadjusted P-
value, we found 41 SDE metabolites that were increased and 36 that
were decreased relative to 12AL (P ≤ 0.05). Using IPA, one metabolic
pathway, glutamine degradation I, was found to be altered in 24AL
relative to 12AL (P = 0.018).
Correlations between CR-dependent metabolites and CR-
dependent physiological traits
To explore the metabolites that had a graded response further, we
correlated them (Pearson’s correlation) with circulating hormone levels
(Table S3), major urinary proteins (MUPs) and markers of oxidative stress
(Table S4), measures of which are detailed in our previous paper (Mitchell
et al., 2015b). We found that circulating levels of leptin correlated
negatively with S1P and sphingomyelin (SM) and positively with ceramide
(Fig. 4A, S1P r = 0.431, P = 0.043 and SM r = 0.401, P = 0.048, Cer
P = 0.597, P = 0.002). These sphingolipids, in addition to the facilitator
of fatty acid oxidation, L-carnitine, correlated negatively with IGF-1 (S1P
r = 0.597, P = 0.001, SM r = 0.595, P = 0.001 and L-c -0.429,
P = 0.027) and MUPs, which are a marker of male reproductive
investment (Fig. 4B, S1P r = 0.646, P < 0.001, SM r = 0.557,
P = 0.003 and L-c r = 0.510, P = 0.004). We also found that L-
carnitine and several other carnitine metabolites correlated positively with
dROMs (derivatives of reactive oxygenmetabolites), which is a measure of
oxidative stress-related metabolites in the blood (Fig. 4C, Table S5).
Leptin levels were significantly associated with levels of white adipose
tissue. Residual leptin (adjusted for white adipose tissue level) was not
significantly associated with S1P, sphingomyelin or ceramide levels (S1P
r = 0.07, P = 0.66, SM r = 0.11, P = 0.50 and Cer r = 0.19, P = 0.25).
Additionally, we correlated these metabolites with physiological data
(Mitchell et al., 2015a,c, 2016a). S1P and sphingomyelin were nega-
tively correlated with body mass (S1P r = 0.761, P < 0.001 and SM
Table 1 Number of significantly differentially expressed (SDE) metabolites, relative
to 12AL control for each CR treatment level and the 24AL group. BH adjusted
corrected for false discovery rate P ≤ 0.05
24AL 10CR 20CR 30CR 40CR
Up 0 0 21 58 88
Total 0 1 37 100 163
Down 0 1 16 42 75
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r = 0.453, P = 0.019) and positively correlated with food anticipatory
activity (activity in the 2 h before food supply: FAA) (S1P r = 0.771,
P < 0.001 and SM r = 0.365, P = 0.024), whereas ceramide correlated
in the opposite direction (BM r = 0.550, P = 0.003 and FAA r = 0.412,
P = 0.015). Levels of S1P strongly negatively correlated with Body
temperature (Tb) (r = 0.770, P < 0.001), previously we found that Tb
over the last 20 days of CR correlated negatively with the level of
restriction.
The conjugated bile acids taurocholic acid (30CR, P = 0.047 and
40CR, P = 0.001) and taurochenodeoxycholate (P = 0.028) were SDE at
higher levels of restriction and showed a graded response to CR.
However, they did not correlate with any of the hormones or oxidative
stress parameters.
Injection of S1P and S1PR1 agonist does not cause a change in
Tb or food intake
Despite the relationship between CR and S1P, and S1P with body mass,
FAA and Tb, we found no indication that peripheral injection of S1P, or
an S1P receptor agonist (SEW2871), had any effect on Tb or food intake.
Single 100 ng and 200 ng (injected as 100 lL and 200 lL, respectively)
injections were given in triplicate on different days at 1000 h (n = 5).
Model selection indicated that using activity alone gave the best model
when using Tb as the dependent variable (Table S6) and using the
intercept alone gave the best model for food intake (Table S7).
Treatment as a fixed effect did not significantly explain Tb (P = 0.558,
Table S8 and Table S9), nor did using treatment as a random effect with
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Fig. 1 (A) Venn diagram showing the
overlap between significantly differentially
expressed metabolites. Each CR group (10,
20, 30, and 40) was compared to the 12AL,
adjusted P ≤ 0.05. (B) Orthogonal partial
least-squares discriminate analysis (O-PLS-
DA) demonstrates the differentiation effect
of diet in metabolomic profiles. The O-PLS-
DA plot showed significant separation
among samples on the basis of the model
quality parameters: R2X, Q2, RMSEP. The
first two principal components explained
59% of the data. Adjusted P ≤ 0.05.
Table 2 For each CR group in comparison with the 12AL group. The percentage of metabolites up- and downregulated for each of the top six canonical pathways
calculated using IPA. P-values are based on the number of metabolites found in liver samples relative to total number of molecules in known metabolic pathway
Pathway
40 CR 30 CR 20 CR 10 CR
Up Down P-value Up Down P-value Up Down P-value Up Down P-value
Ceramide signalling 50% 25% <0.001 50% 25% <0.001 50% 25% <0.001 50% 25% 0.001
S-1-P signalling 50% 25% <0.001 50% 25% <0.001 50% 25% <0.001 50% 25% 0.001
Methionine salvage II 33% 17% <0.001 50% 17% <0.001 50% 17% <0.001
Sphingomyelin metabolism 50% 17% <0.001
L-carnitine biosynthesis 50% 0% 0.003 50% 0% <0.001
Phospholipases 0% 50% 0.003
Glycine betaine degradation 23% 23% 0.001 23% 23% 0.002
Cysteine biosynthesis III 23% 23% 0.001
Sphingosine and S-1-P metabolism 40% 10% 0.001
NGF signalling 17% 17% 0.006
Phenylalanine degradation IV 28% 17% 0.001
Glutamine biosynthesis I 67% 0% 0.002
Asparagine biosynthesis I 43% 14% 0.003
Methionine degradation I 38% 13% 0.004
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ID (Table S6, model 1). Treatment or activity as fixed effects did not
significantly affect food intake, in either the light or dark period, nor did
the interaction between treatment and activity (Table S8 and S9).
Discussion
Graded CR provides novel insights into the effects of CR
In contrast with earlier studies, which typically included a single
treatment level, we used graded CR treatment groups (but see also
Nogueira et al., 2012; Kim et al., 2016). This design enabled us to show
not only that there was an increasing number of SDE metabolites with
increasing CR, but also that many of these metabolites, including L-
carnitine, S1P and taurocholic acid, were increasingly upregulated with
increasing CR.
The increase in SDE metabolites was independent of liver
structure
We have previously shown that liver mass decreases by 17.5, 27.6, 25.6
and 27.7% at restriction levels of 10, 20, 30 and 40%, respectively,
relative to the 12AL control (Mitchell et al., 2015c). These losses were
significant between 12AL and the CR groups, but not between CR
groups. In contrast, we observed a rise in the number of SDE metabolites
relative to 12 AL as restriction increased. Given that the number of SDE
metabolites continued to rise with an increase in CR, and that liver mass
was not responsive to the level of restriction, the changes in metabolic
pathways appeared independent of tissue mass loss. This supports the
idea that although liver morphology is relatively protected with CR and
age, liver function is plastic when confronted with such challenges.
Lipid and glycolysis pathway remodelling occurs in the liver
metabolome with CR
Previous metabolomic analyses on the livers of C57BL/6 CR mice suggest
that glycolysis, fatty acid oxidation and amino acid pathways are
significantly altered (Collino et al., 2013; Fok et al., 2014; Jove et al.,
2014). These changes were consistent with studies that indicate
metabolic reprogramming through the shift from lipogenesis to lipolysis
during CR is beneficial in both male and female C57BL/6 mice (Bruss
et al., 2010; Kuhla et al., 2014). In our study, we found that several
pathways involved in fatty acid metabolism were altered with CR, which
further supports these hypotheses. In terms of a graded response, which
is important when we consider the most influential pathways on
lifespan, short-term CR appeared to have most effect on sphingolipid
and carnitine metabolism. However, methionine, cysteine, phenylala-
nine, glutamine, asparagine, lysine and tryptophan pathways appeared
modulated at varying levels of CR in the present analysis. This is in
concordance with studies that found changes in a wide range of
different amino acids in the liver with CR in both C57BL/6 and DBA2
mice (Collino et al., 2013; Mitchell et al., 2016b). Pathway analyses did
not reveal that amino acid pathways were particularly altered with CR,
this is in contrast with the results of (Mitchell et al., 2016b); however, in
that study CR was lifelong, and the most significant amino acid changes
*** ***** *
* *** *** *** *** * *
Fig. 2 Sphingosine-1-phosphate and precursors pathway indicating cellular effects. Boxplots indicate intensity level of each metabolite across groups (n = 7–9), showing
outliers, min, max and interquartile range. Red = upregulated, blue = downregulated, grey = not significantly changed, white = undetected in sample. P-values are from
SDE metabolite analysis of each CR group relative to 12AL. * P < 0.05, ** P < 0.01, *** P < 0.001.
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in C57BL/6 mice appeared in the females. As our mice were male and
the duration of restriction shorter, it may be that less significant amino
acid changes are seen after 3 months of restriction. We identified a
decrease in D-ribonate as the only consistently SDE metabolite at all CR
treatment levels relative to 12AL. This indicated that glycogen
breakdown in the livers of CR mice was reduced after 3 months of
CR, perhaps because glycogen stores were depleted during the initial
phase of restriction. This would also be consistent with a shift towards
lipolysis, which supports the idea that during CR, there is an increase in
oxidation of fatty acids as opposed to glucose utilization. This
** **
**
* * *
** ** ** *
** *** ***
* *
Fig. 3 Pathway showing the production of L-carnitine from L-methionine and L-lysine. Boxplots indicate intensity level of each metabolite. Red = upregulated,
blue = downregulated, grey = not significantly changed, white = undetected in sample. P-values are from SDE metabolite analysis of each CR group relative to 12AL.
* P < 0.05, ** P < 0.01, *** P < 0.001.
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compliments transcriptomic liver data from previous studies, which
indicate CR increases fatty acid mobilization and metabolism in several
strains of mice and rats (Selman et al., 2006; Plank et al., 2012; Collino
et al., 2013). Three key metabolic groups showed increased responses to
the levels of restriction. Independently, these have all been associated
previously with CR and aging.
S1P and ceramide
S1P and ceramide are associated with the beneficial effects of CR in male
Wistar rats and C57BL/6 mice (Collino et al., 2013; Babenko &
Shakhova, 2014) and lifespan regulation in mammals (Lightle et al.,
2000; Huang et al., 2014). They are thought to have evolved to protect
cells from environmental stress (Van Brocklyn & Williams, 2012). Reactive
oxygen species (ROS) can act as a switch for the interconversion of these
metabolites, and during excess oxidative stress, ceramide is produced
and sphingosine kinase 1 is degraded, reducing levels of S1P and tipping
the balance towards apoptosis (Van Brocklyn & Williams, 2012). S1P and
sphingomyelin (increased with CR) correlated negatively with circulating
leptin levels, whereas their precursor, ceramide (decreased with CR), was
positively correlated with leptin (Fig. 4A). Leptin was reduced with
increasing levels of restriction and was strongly positively correlated
with adiposity (Mitchell et al., 2015b). As leptin is a key regulator of
long-term energy balance, its reduction during CR may be antagonis-
tically regulating S1P and ceramide (Rosen & Spiegelman, 2006).
Although no direct relationship between leptin signalling and S1P or
ceramide has yet been discovered, and we found the relationship
between these metabolites and leptin may be completely explained by
adiposity, low levels of ceramide have been associated previously with
reduced mass and improved insulin signalling in the liver and muscle
tissue in ob/ob and obese mice (Yang et al., 2009). Moreover, S1P-
stimulated cells have shown a reduction in insulin-induced leptin
synthesis in rats (Jun et al., 2006). Our study suggests that this
relationship may be important in the beneficial effects or CR, particularly
as the pathway shows a graded response to CR levels.
It is possible that alongside leptin and insulin pathways, S1P and
ceramide may have an important role in signalling the energy status of
the animal in the brain through specific kinases and phosphatases (van
Echten-Deckert et al., 2014). Previous work suggested that in the
hypothalamus, S1P regulates energy homeostasis in rats. Microinjection
of S1P into the third ventricle of rats increased Tb and energy
expenditure, and microinjection of S1PR1 agonist SEW2871 decreased
food intake and activated leptin signalling (Silva et al., 2014). We also
observed correlations between these metabolites and aspects of
physiology of the CR mice, including Tb and FAA, but the correlation
with respect to Tb was opposite that previously observed in the brain.
One distinctive response in our mice was a large increase in FAA, and in
addition the level of FAA was correlated with transcriptomic levels of
several key hunger signalling neuropeptides in the hypothalamus
(Derous et al., 2016). The association of S1P and Tb is potentially
significant in the context of the potential causal relationship between Tb
and longevity. In the longest-lived rodent, the naked mole-rat (Hetero-
cephalus glaber), low Tb is thought to contribute to its longevity.
Furthermore long-lived Ames dwarf mice have a lower Tb than wild-type
mice, potentially related to deficiencies in thyroid-stimulating and
growth hormones and lower insulin levels (Keil et al., 2015). Hcrt-
UCP2 mice, which overexpress UCP2, also have reduced Tb and
increased lifespan, thought to be related to increased energy efficiency
(Conti et al., 2006). We also saw that Tb correlated with body fat, leptin
and IGF-1. Due to its relationship with Tb and its role as a bioactive
signalling molecule, we hypothesized that S1P may be a peripheral signal
involved in the stimulation of these hunger signalling pathways
alongside leptin, insulin and IGF-1. To explore whether these correlations
reflected an underlying causal role for S1P signalling, we performed an
experiment to evaluate the role of S1P on these traits. However, we
found that peripherally injecting S1P (intraperitoneally) had no effect on
Tb, activity level or food intake. The lack of effect seen may indicate that
S1P is not causally linked to the responses observed under CR, such as
decreased physical activity, increased FAA and lowered Tb. However, this
could be due to the peripheral injection of S1P not reaching a certain
threshold in the liver to be effective, compared to the previous study
where S1P was injected directly into the brain of rats (Silva et al., 2014).
The physical changes we see with CR, along with the increase in S1P,
may be downstream of other CR related responses such as lowered
leptin levels. The observed increase in S1P may be liver-specific and
acting to promote cell survival, immune cell trafficking, cell motility and
histone modification (van Echten-Deckert et al., 2014; Gomez-Mu~noz
et al., 2015). The increase in S1P we see with CR may also be acting as a
switch to reduce ceramide, which can promote inflammation through
NF-ƙB (nuclear factor kappa-light-chain enhancer of activated B cells) in
liver mitochondria, and conversion into S1P may act to attenuate this
response (Gomez-Mu~noz et al., 2015).
Table 3 Significant pathways for each CR level relative to 12AL from the pathway
enrichment analysis computed by mummichog. Based on the m/z scores of
significant metabolites from the empirical Bayes linear modelling from the 40CR –
12 AL comparison (P ≤ 0.05)
Pathways Overlap size Pathway size P-value
40CR
Carnitine shuttle 8 11 0.00226
Lysine metabolism 11 19 0.00337
Methionine and cysteine metabolism 12 26 0.01553
Drug metabolism – other enzymes 3 4 0.0231
Vitamin B3 (nicotinate and
nicotinamide) metabolism
6 12 0.02696
Porphyrin metabolism 4 7 0.03105
Saturated fatty acids beta-oxidation 2 2 0.04654
Glycine, serine, alanine and
threonine metabolism
13 32 0.04987
30CR
Carnitine shuttle 7 11 0.00522
Pyrimidine metabolism 11 23 0.00891
Lysine metabolism 9 19 0.01347
Glutamate metabolism 6 11 0.01369
Butanoate metabolism 6 11 0.01369
20CR
Carnitine shuttle 6 11 0.0016
Drug metabolism – cytochrome P450 9 27 0.00733
Glycerophospholipid metabolism 7 20 0.00889
Saturated fatty acids beta-oxidation 2 2 0.01387
Glycosphingolipid metabolism 6 18 0.01742
Vitamin E metabolism 4 11 0.02752
Selenoamino acid metabolism 3 7 0.02998
10CR
Lysine metabolism 6 19 0.01463
Glycerophospholipid metabolism 5 20 0.05926
Drug metabolism – other enzymes 2 4 0.06117
Pyrimidine metabolism 5 23 0.11322
Tryptophan metabolism 8 40 0.12019
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It appears that a reduction in the ceramide: S1P ratio may be
beneficial as ceramide is associated with rapid ROS production to initiate
apoptotic cell death through TNF-a signalling (Lecour et al., 2006;
Dumitru et al., 2007). Sphingosine kinase 1, which converts sphingosine
to S1P, is thought to act as a switch enzyme that can affect the S1P/
ceramide ratio downstream of ROS in stress signalling (Van Brocklyn &
Williams, 2012). However, we found that ceramide was positively
correlated with superoxide dismutase, a major antioxidant defence
system against superoxide anions which cause cell stress (Fukai & Ushio-
Fukai, 2011) and negatively correlated with reactive oxygen metabolites
(ROMS) in the blood. It is unclear whether bioactive ceramide had a
direct effect on the level of ROMS in the blood, as measures of oxidative
stress are tissue-dependent (Xu et al., 2014).
As with ceramide we found that MUPs significantly decreased with
increasing CR, MUPs are nonvolatile components found in urine, which
are a marker of reproductive investment (Mitchell et al., 2015b). This
result is likely to be unique to male mice, as they produce significantly
more MUPs in their urine than female mice, which are stimulated by
testosterone, growth hormone and thyroxine (Knopf et al., 1983). MUPs
were also negatively correlated with S1P, sphingomyelin and L-carnitine.
MUPs are thought to cause oxidative stress during their synthesis in male
mice. These results suggest that in addition to metabolic remodelling,
these metabolites and their associated pathways may be augmenting
reductions in reproductive investment to conserve energy and decrease
ROS production.
Circulating hormone levels may cause an increase in L-
carnitine and decrease in L-methionine
Pathway analysis indicated that fatty acid metabolism (increase in b-
oxidation), fatty acid transport (increase in the carnitine shuttle) and fatty
acid messengers (S1P and ceramide) were significantly altered, even at
lower levels of CR. We also found that all identified carnitines and
carnitine derivatives were increased with CR, and this has implications
for longevity, as in Drosophila L-carnitine shows a highly significant
decline with age (Hoffman et al., 2014). L-carnitine shuttles fatty acids
across the mitochondrial membrane, where they can be processed by b-
oxidation enzymes to ultimately generate ATP (Flanagan et al., 2010;
Pekala et al., 2011). Studies have shown that L-carnitine supplementa-
tion has positive effects in obese and diabetic humans, as well as benefits
in cats and mice (Levin et al., 1999; Blanchard et al., 2002; Mingorance
et al., 2012). The L-carnitine biosynthesis pathway was significantly
upregulated at 30 and 40CR, and all metabolites detected in this
pathway showed a graded response (Fig. 3). It is thought that a high
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Fig. 4 Overview of SDE metabolites (BH adjusted P < 0.05) which exhibited a graded response to CR and correlations with physiological parameters (Pearson’s correlations
adjusted P ≤ 0.05). (A) Sphingolipids and their relationship with parameters involved in hunger signalling. (B) Sphingolipids and L-carnitine and the relationship with markers
of oxidative stress and antioxidants. (C) L-carnitine and its precursor L-methionine and the relationship with physiological parameters, hormones and oxidative stress markers.
FAA = food anticipatory activity, MUPs = major urinary proteins, SOD = superoxide dismutase, dROMs = derivatives of reactive oxygen metabolites. Connections between
metabolites and other measures indicate correlations, where red equals a positive and blue a negative correlation.
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proportion of L-carnitine is endogenously produced through L-lysine and
L-methionine (Krajcovicova-Kudlackova et al., 2000). Although the
metabolite precursors of methionine production (L-homocysteine and
betaine) increased with restriction, levels of methionine were decreased.
One possibility is that methionine was decreased due to incorporation
into the L-carnitine biosynthesis pathway, thereby improving fatty acid
transport efficiency across the mitochondrial membrane.
In the skeletal muscle of rats, carnitine supplementation increases IGF-
1 plasma levels, which activates the IGF-1/PI3K/Akt signalling pathway
(Keller et al., 2013). However, we saw that L-carnitine correlated
negatively with levels of IGF-1 as well as MUPs, although we measured L-
carnitine in the liver. A study using mouse embryonic fibroblasts showed
that although low levels of L-carnitine activated the IGF-1/PI3K/Akt
pathways, high levels of L-carnitine decreased the expression of IGF-1
and significantly inhibited the pathway (Ge et al., 2015). This may
indicate that carnitine regulation of IGF-1/PI3K/Akt pathways is dose
dependent. Although we did not measure the direct effect of L-carnitine
on the IGF-1/PI3K/Akt pathway, we did see that with increasing CR, IGF-
1 decreased and L-carnitine increased. The regulation of the IGF-1/PI3K/
Akt pathways is pertinent to nutritional lifespan studies as direct and
indirect targets of Akt include mTOR and FOXO. Inhibition of mTOR
increases lifespan in several species and can be reduced through CR
(Nave et al., 1999; Johnson et al., 2013).
Increasing bile acids may be linked to the control of metabolic
pathways
As CR puts greater demands on the metabolism of lipids, we expected
metabolites involved in fatty acid metabolism to be increased. This not
only held true for the carnitine family, but also for bile acids. Bile acids
break down large fat globules into smaller droplets and promote their
absorption through formation of micelles. This helps stimulate energy
metabolism and improves insulin sensitivity (Chiang, 2013). When
cholesterol builds up in the liver, it can cause damage through fatty
deposits, which cause inflammation (Zheng et al., 2008), but this process
can be alleviated through the production of bile acids for which
cholesterol is a precursor (Javitt, 1994). Bile acids also act as signalling
molecules, which can regulate lipid and glucose metabolism through G
protein-coupled receptors in the liver (Qi et al., 2015). The bile acids
taurocholic acid and taurochenodeoxycholate showed a significant
graded increase with rising CR. Increasing age is associated with reduced
bile acid synthesis in rodents (Ferland et al., 1989) and in humans and is
thought to be related to the growth hormone/IGF axis (Bertolotti et al.,
2007). CR has been shown to reverse the decline in the bile acid synthesis
pathway with age in female C57BL/6 mice (De Guzman et al., 2013). Bile
acids are also ligands for the farnesoid X receptor (FXR). FXR is important
in controlling several metabolic pathways including lipid and glucose
homeostasis and modulating liver regeneration, suggesting that FXR-
induced changes through bile acid activation may underpin some
beneficial effects of CR (Zhang & Edwards, 2008). In conjunction with
the increase in the carnitine shuttle pathway and possible nutritional
modulation through the bioactive signalling molecule S1P, bile acids may
be crucial to metabolic remodelling during CR.
Twelve-hour ad libitum vs. 24-h ad libitum
Underlying our analysis was an initial decision to use 12AL as our control,
as opposed to the more traditionally used 24AL fed control. As the 24AL
group may have eaten immediately prior to culling, the 12AL group
allowed us to separate long-term restriction from short-term starvation
and evaluate the ‘time since last meal’ effect. We demonstrated that the
12AL and 24AL feeding groups showed significantly different metabo-
lomic profiles with 9% of metabolites significantly different (using
unadjusted P-values).
Conclusion
In this study, we found that as the level of CR increased, the number of
SDE metabolites also increased. It is important to note that we saw
significant changes in many age-associated metabolites, in relatively
young mice after only three months of CR. This indicates that short-term
CR as opposed to lifetime CR is sufficient to initiate beneficial remodelling
of liver metabolism in male mice. Pathway analysis showed that CR had
the greatest effect on the carnitine shuttle and synthesis pathways and
on phospholipid metabolism pathways. Interestingly, we did not see
significant changes in amino acid pathways, although large changes in
amino acids were seen in female mice in Mitchell et al., 2016b. As our
mice were male, it may be that metabolic remodelling shows gender-
specific fuel preferences. In addition to the increase in bile acids, these
results are consistent with the notion that during CR, the liver becomes
much more efficient at breaking down lipids and shuttling long-chain
fatty acids to the mitochondria. Furthermore, all of these effects acted in
a graded way to CR, highlighting their potential relevance to longevity.
The pathways and metabolites we highlight may be modulating
improvements in metabolism through promoting utilization of lipids
during CR and regulating energy homeostasis. Correlative data indicate
the S1P/ceramide axis may be working downstream of hunger signalling
pathways such as leptin and insulin/IGF-1; however, we demonstrated
that peripherally it is unlikely to directly affect Tb, FAA or food intake.
Methods
Experimental design
Our data set consisted of metabolomic data from technical triplicates of
48 individual liver samples across six different feeding groups, including
four CR groups and two AL-fed groups. Male mice were allocated to six
treatment groups: 12AL, 24AL and 10, 20, 30 and 40% CR. Sample size
was eight for all groups except 30CR where n = 7 and 40CR where
n = 9. The 12AL group was used as the control. We initiated CR at
20 weeks; this was performed to avoid any effect of CR on development
while retaining effectiveness of increasing lifespan (Yu et al., 1985).
Mice were fed CR (or AL) diets for 12 weeks, before being sacrificed at
32 weeks of age.
Animals
Mice were purchased from Charles River (Ormiston, UK). All procedures
were reviewed and approved by University of Aberdeen ethical approval
committee and carried out under a Home Office issued licence compliant
with the Animals (Scientific Procedures) Act 1986. This strain is already
known to live longer under CR (Turturro et al., 1999; Swindell, 2012).
More information on procedures and measures can be found in Data
S10 and the first paper of this series (Mitchell et al., 2015c).
Liver metabolite extraction
Individual frozen mouse liver samples ( 25 mg) were homogenized
using an ULTRA-TURRAX dispenser T-25 Basic (IKA, Staufen, Ger-
many) at level 5 in 1000 lL of chloroform: methanol: water (1:3:1) at
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4°C. Samples were agitated for 1 h at 4°C and centrifuged at 13 000 g
for 3 min at 4°C. Supernatant was aliquoted into 180 lL samples and
stored under argon at 80°C. Samples were analysed with LC-MS using
an OrbitrapTM ExactiveTM mass spectrometer at the Glasgow Polyomics
facility. The ZIC-pHILIC (zwitterionic ion chromatography–hydrophilic
interaction chromatography) platform detects mainly polar molecules,
and nonpolar lipids can be identified in the wash-through. A panel of
known common metabolites are run alongside samples. Raw peak
intensities were obtained for each metabolite, and where possible
metabolites were identified by their retention times, mass to charge ratio
(m/z ratio) and comparison to standards. As part of quality control,
blanks containing chloroform: methanol: water and a pooled sample
containing all 48 samples were analysed alongside the liver samples.
Data preprocessing
A total of 6550 features across all samples including adducts, fragments
and metabolites were detected. We filtered these features to unique
metabolite chromatographic peaks, which included 505 identified and
381 unidentified metabolites. Among 886 metabolite features, 1.9% of
the metabolite intensities were unclassified due to either low metabolite
concentration, poor ionization, machinery limitations including detection
sensitivity and ion suppression or true lack of presence (Huan & Li, 2015).
To fill in these missing values, we imputed using a random forest
regression approach (Stekhoven & B€uhlmann, 2012; Gromski et al.,
2014) using the missForest package (Stekhoven, 2011) for metabolites
which had peaks that were significant in at least one group. Raw peak
intensities for each sample were normalized by centring around the
median for each metabolite in each sample using the Metabolomics
package (De Livera & Bowne, 2013), then log2-transformed.
Statistical modelling of differential metabolite expression
To detect SDE metabolites between treatment groups, an empirical
Bayes moderated linear model was fitted to each metabolite (Smyth,
2004). The empirical Bayes approach shrinks the estimated sample
variances by borrowing information from across metabolites. Compar-
isons across metabolite fold-changes were made between each level of
CR (10, 20, 30 and 40%) and 24AL relative to 12AL. P-values for each
comparison were adjusted using the Benjamini–Hochberg (BH) proce-
dure using a false discovery rate of 5% (Benjamini & Hochberg, 1995;
Ferreira, 2007). We used the package Devium to produce the O-PLS-DA
plot and to complete the validation steps (Wanichthanarak et al., 2015).
O-PLS-DA allows us to discriminate between groups in multivariate data
(Westerhuis et al., 2010).To validate the O-PLS-DA, we carried out 1000
simulations on randomly permuted groups to compare the modelled
data to random expectation. We generated a pseudo training set by
splitting the data into a testing and training set.
Biological pathway analysis
We assigned KEGG (Kyoto Encyclopaedia of Genes and Genomes), HMDB
(Human Metabolome Database), CAS (Chemical Abstracts Service) and
CID (PubChem Compound Identifier IDs) IDs to 432 of the 505 identified
metabolites. To infer biological meaning from our identified SDE metabo-
lite set, we used IPA. This allowed us to determine whether the pathways
were significantly altered relative to the 12AL control, based on the
number ofmetabolites in each pathway and their abundances. Therewere
147 metabolites that were SDE between the CR groups and 12AL
(unadjusted P ≤ 0.05) and had the IDs mentioned above. IPA takes
advantage of the Ingenuity Knowledge Base, a repository of biological
and chemical information manually curated from published literature,
public and private databases and in-house expert knowledge.
We used mummichog to analyse biological activity in each treatment
group from the rawm/z ratios (Li et al., 2013).Mummichog looks up m/z
features in its human network model, an integrated model from KEGG,
UCSD BiGG and Edinburgh Model (Li et al., 2010). P-values are based on
the number of significant metabolite hits per pathway, and identifications
are made based on the metabolites in those enriched networks. The
inherent differences and biases that exist within the IPA and mummichog
databases expectedly lead to slightly different pathway results.
Correlations with physiological parameters
Circulating hormone levels and measures of oxidative stress were
correlated (Pearson’s correlation) with all metabolite intensities for each
individual mouse. The average FAA of the last 20 days of treatment, core
Tb over the final two weeks and the final body mass were also
correlated. Associated P-values for each correlation were adjusted using
the BH procedure using a false discovery rate of 5%.
S1P experiment
Information on experimental set-up can be found in Data S11.
Single intraperitoneal S1P (100 ng and 200 ng), SEW2871 (100 ng
and 200 ng) or saline control injections (triplicates) were performed at
16 weeks. Injections were performed at 1000 h, after weighing. S1P and
SEW2871 were obtained from the Cayman Chemical Company (Ann
Arbor, MI, USA). Dosages were based on Silva et al. (2014) and Dong
et al. (2014). For analysis of Tb, data were averaged between 1230 h and
1330 h (n = 5). This time frame was chosen as Tb had stabilized after
increasing from handling and injection, but was 7 h before lights out
when activity and Tb increase due to diurnal rhythms. Food intake (g) was
split into light (11:00–16:00) and dark phases (16:00–04:00) and summed
across mice (n = 6). To determine whether high and low S1P and
SEW2871 had an effect on Tb and food intake, we used a linear mixed-
effects modelling approach using the nlme package (Pinheiro et al.,
2016). Injection treatment (saline control, S1P high, S1P low, SEW2871
high and SEW2871 low) and activity level were used as fixed effects and
mouse IDwas used as a randomeffect. Model selectionwas performed by
minimizing the Akaike information criterion (AIC) and model validation
performed using standard residual plots (Bozdogan, 1987).
All statistical analyses were performed using the R statistical environ-
ment (R Core Team, 2015).
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